Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LMB-100 |
Trade Name | |
Synonyms | RG7787|RO-6927005|RO6927005|LMB100 |
Drug Descriptions |
LMB-100 is an immunotoxin that targets mesothelin, potentially resulting in antitumor activity (PMID: 27863199, PMID: 32611684). |
DrugClasses | |
CAS Registry Number | 1841500-93-3 |
NCIT ID | C121653 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ipilimumab + LMB-100 | Ipilimumab LMB-100 | 0 | 1 |
LMB-100 | LMB-100 | 0 | 3 |
LMB-100 + Nab-paclitaxel | LMB-100 Nab-paclitaxel | 0 | 2 |
LMB-100 + Pembrolizumab | LMB-100 Pembrolizumab | 0 | 2 |
LMB-100 + SVP-rapa | LMB-100 SVP-rapa | 0 | 1 |
LMB-100 + Tofacitinib | LMB-100 Tofacitinib | 0 | 1 |